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Purpose: To study associations between body size at birth and age-related macular degeneration 44 
(AMD) in old age. 45 
Methods: The study sample consists of 1497 community-dwelling individuals (56.1% women) aged 46 
67 to 89 years with birth data and retinal data collected twice in old age 5 years apart. Birth data 47 
(weight, length, birth order) were extracted from original birth records. Digital retinal photographs 48 
were graded to determine AMD status. Data on covariates were collected at the baseline physical 49 
examination in old age. Multivariable regression analyses were used to study the association 50 
between birth data and AMD adjusting for known confounding factors, including birth year cohort 51 
effects. 52 
Results: The prevalence and 5-year incidence of any AMD were 33.1% and 17.0%, respectively. 53 
Men and women born in 1930-1936 were significantly leaner and slightly longer at birth compared 54 
to those in earlier birth cohorts. There were no consistent associations between weight, length or 55 
ponderal index (PI) at birth and AMD in old age even when stratified by birth cohort. AMD 56 
prevalence (39.8%) and 5-year incidence (28.6%) were highest in individuals who were in the 57 
highest quartile of PI at birth and who were obese in old age. 58 
Conclusion: Body size at birth was not consistently associated with AMD in old age, suggesting 59 
that intrauterine growth might have little direct importance in the development of AMD in old 60 
age. It is possible that some yet unknown factors related to larger size at birth and obesity in old 61 
age may explain differences in the prevalence and incidence of AMD in the aging population. 62 
 63 




The proportion of individuals aged 60 years and older is projected to double from 12 to 24% by the 66 
year 2050 making it the fastest growing demographic group in developed countries (United Nations, 67 
Department of Economic and Social Affairs 2015). Age-related macular degeneration (AMD) is a 68 
leading cause of blindness in this population (Mitchell et al. 2018) and the number of people 69 
suffering from AMD is projected to increase from 196 million in the year 2020 to 289 million in 2040 70 
(Wong et al. 2014). AMD is a multifactorial condition that involves several risk factors, of which older 71 
age, smoking, dietary habits and genetic factors are among the most well-documented (Lambert et 72 
al. 2016). In addition, other chronic conditions including cardiovascular disease, hypertension and 73 
obesity, have been associated with an increased risk of AMD (Cheung & Wong 2014). Longitudinal 74 
population-based data from the Beaver Dam Eye Study in Wisconsin has suggested that a birth 75 
cohort effect may influence the prevalence of AMD (Huang et al. 2003). However, relatively little is 76 
known about possible associations among early life factors from conception through gestation that 77 
influence health and morbidity throughout life, including signs of AMD in old age.  78 
 79 
The Developmental Origins of Health and Disease (DOHaD) hypothesis highlights the importance of 80 
exposures that occur during critical phases of development and the long-lasting effects they may 81 
have on later health (Barker 1995, Barker 1998). Evidence from meta-analyses of epidemiological 82 
studies stress  developmental influences in susceptibility to clinical risk factors associated with  AMD 83 
(Cheung & Wong 2014), importantly cardiovascular disease (Wang et al. 2014) and hypertension 84 
(Zhang et al. 2013), as the result of poor growth indicated by small size at birth, as opposed to  85 




The retina undergoes rapid development during early gestation and continues to mature post-88 
partum  (Hendrickson 2016). Facing undernutrition in utero, organisms prioritize growth of vital 89 
tissues including the brain at the expense of others, resulting in smaller size at birth. Low birth 90 
weight has been associated with altered ocular dimensions in children (Li et al. 2014) and adults 91 
(Fieß et al. 2019). To our knowledge, there are 3 earlier cross-sectional studies reporting on the 92 
association between body size at birth and AMD, which show inconsistent results. In a multiethnic 93 
study from the United States, higher self-reported birth weight was associated with early AMD, 94 
assessed in 1993-1995 in a White population (n=4083, mean age 60 years, 208 AMD cases) but not 95 
in the study population as a whole (Liew et al. 2008). Findings from a UK population consisting of 96 
White participants found evidence of an association between higher birth weight and head 97 
circumference-to-birth weight and early or late AMD among 380 individuals aged 66 to 75 years 98 
(Hall et al. 2002). However, null findings were reported by another study from Hertfordshire, UK, 99 
which included 717 participants of similar age (Sayer et al. 1998). Using longitudinal data from a 100 
subset of participants from the Age, Gene/Environment Susceptibility-Reykjavik (AGES) study on 101 
whom birth data were available, we investigated associations between body size at birth and both 102 
prevalent and incident AMD in old age.103 
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Materials and methods 104 
Study population 105 
The AGES study (Harris et al. 2007) is a population-based cohort study comprising 5764 participants 106 
who were randomly selected from survivors (n=11,549) of the Reykjavik Study (Sigurdsson et al. 107 
1993). Clinical assessment for AMD was first performed among 5272 participants at a study visit 108 
(AGES-I) during 2002-2006 (Jonasson et al. 2011). Of these, 2868 survivors provided information on 109 
AMD at a 5-year follow up visit (AGES-II) during 2007-2011 (Jonasson et al. 2014). Original midwives’ 110 
birth records for 1696 AGES participants were available for this analysis (Birgisdottir et al. 2002). 111 
Data on body size at birth, AMD and covariates were available for 1497 participants whose mean 112 
age was 75.2 years at the baseline AGES-I examination. The study was approved by the Icelandic 113 
National Bioethics Committee (VSN 00-063) and by the Institutional Review Board of the U.S. 114 
National Institute on Aging, National Institutes of Health. The study was conducted in accordance 115 
with the principles of the Declaration of Helsinki. All participants signed an informed written 116 
consent. 117 
 118 
Birth data 119 
Birth data were extracted from birth records obtained from the National Archives of Iceland 120 
(Gunnarsdottir et al. 2002). Birth weight was recorded to the nearest 50 g and length in centimeters 121 
from crown to heel. Ponderal index (PI) was calculated as [kg/m3]. Birth order was grouped into first, 122 
second, third and fourth or later born. The average body size of the survivors of the Reykjavik Study 123 
(n=4828) was similar to that of participants included in the present study (Birgisdottir et al. 2002). 124 
Information on gestational age was not available but at that time a newborn was considered 125 
preterm if they were less than 48 cm long at birth (Gunnarsdottir et al. 2002). By this definition, 126 
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there were 18 preterm births in this sample. Exclusion of preterm births (n=18) from the analyses 127 
did not change the results. 128 
 129 
Age-Related Macular Degeneration 130 
Fundus photography was performed using a standardized protocol as described in detail elsewhere 131 
(Jonasson et al. 2011). In brief, using a Canon CR6 nonmydriatic camera with a Canon D60 camera 132 
back, two 45-degree digital retinal images, one centered on the optic nerve and the other on the 133 
macula, were taken through the pharmacologically dilated pupil of each eye. The retinal images 134 
were evaluated by masked graders at the University of Wisconsin Ocular Epidemiology Reading 135 
Center for assessment of AMD in a semiquantitative fashion. EyeQ Lite image processing software 136 
was used with a standard AMD grading protocol including the modified Wisconsin Age-Related 137 
Maculopathy Grading System (Jonasson et al. 2011, Klein et al. 1991, Klein et al. 2006). Early AMD 138 
was defined as having any soft drusen and pigmentary abnormalities or the presence of large soft 139 
drusen ≥125 µm in diameter with a large drusen area (>500 µm diameter circle) or large (≥125 µm 140 
in diameter) soft distinct drusen in the absence of late AMD. Any AMD included early AMD and late 141 
AMD, defined as presence of at least one of the following: geographical atrophy or exudative AMD 142 
(pigmental epithelial detachment, subretinal hemorrhage, visible subretinal new vessel, subretinal 143 
fibrous scar or later laser treatment scar for AMD). Inter and intraobserver agreement on the AMD 144 
classification was found to be excellent (Jonasson et al. 2011). 145 
 146 
Covariates 147 
The participants were categorized into 3 distinct geo-economic birth cohorts according to their year 148 
of birth: 1914 to 1924 (24.5% of the participants), 1925 to 1929 (32.2%) and 1930 to 1936 (43.3%). 149 
Data on covariates from old age were collected at the first AGES clinical examination. Smoking 150 
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history was grouped into never smokers, ex-smokers and current smokers. Educational attainment 151 
was dichotomized as having primary or secondary education and college or university education. 152 
Body mass index (BMI) was calculated as weight divided by height squared [kg/m2]. Coronary heart 153 
disease was defined as having documented hospital reports of a myocardial infarction, angioplasty, 154 
or coronary artery bypass surgery. Diabetes was defined as having a history of diabetes, use of 155 
glucose-modifying medication or HbA1c level ≥ 6.5%. Total cholesterol and high-density lipoprotein 156 
cholesterol (HDL) were measured in the IHA laboratory from blood samples using standard 157 
methods. Information on Complement Factor H (CFH) polymorphism (rs1061170), genotyped by 158 
Illuminia Genotyping Services, San Diego, California, was available for a subset of individuals who 159 
participated in a candidate gene SNP array. 160 
 161 
Statistical Methods 162 
For comparing characteristics of the study population, Pearson’s χ2 -test was used for categorical 163 
variables and analysis of variance for continuous variables. Since body size at birth varied by birth 164 
cohort and sex, results were stratified by birth cohort and sex. Due to differences for birth weights 165 
and lengths, which were polarized further between men and women within cohorts, the focus of 166 
subsequent analyses was the summary measure ponderal index. The association between body size 167 
at birth and AMD in old age was investigated with multiple logistic regression models. Ponderal 168 
index was categorized into three groups representing low (lowest quartile), normal (25th to 75th 169 
percentile) and high (highest quartile) ponderal index, with cut-offs at 24.0 and 28.0 kg/m3, 170 
respectively. In old age, the participants were classified as either normal weight (BMI < 25 kg/m2), 171 
overweight (BMI 25.0-30.0 kg/m2) or obese (BMI > 30kg/m2). The analyses were first adjusted for 172 
birth cohort (if not stratified) and then subsequently for the old age variables: educational 173 
attainment, body mass index, smoking status, alcohol consumption, coronary heart disease and 174 
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diabetes, total cholesterol, and HDL cholesterol. Birth order was not associated with AMD and was 175 
not included in the regression models. CFH was also not included due to its limited availability in the 176 
sample. Two-tailed analyses, assuming a 95% confidence level, were completed using SAS version 177 




At the mean age of 75.2 years (SD 4.9, range 66 to 89 years), 391 (26.1%) participants had early and 180 
105 (7.0%) participants had late AMD. Of those who did not have AMD at the first visit, 123 (17.0%) 181 
developed early or late AMD by the 5-year follow-up visit. Characteristics of the men and women 182 
according to birth cohort are presented in Table 1. The proportion of never smokers was highest 183 
(43.7%) in the oldest cohort and lowest (33.9%) in the youngest cohort and consistently higher 184 
among women than men. The prevalence of coronary heart disease and diabetes increased with 185 
older age and were higher among men than women. Among those with birth data, the availability 186 
of AMD data by mortality is presented in the Supplementary Table. 187 
 188 
In Table 1, the youngest cohort weighed less and was leaner at birth than the two older cohorts. 189 
Mean birth weight was less [3669 g (SD 509)] for the youngest cohort born 1930-36 than for the 190 
oldest cohort born 1914-24 [3792 g (SD 568)], which was also true for ponderal index, 24.9 kg/m3 191 
(SD 2.7) and 26.7 kg/m3 (SD 3.7), respectively. In contrast, mean length at birth was slightly longer 192 
for the youngest cohort compared to the older two cohorts. Ponderal index varied slightly by AMD 193 
status in the three birth cohort groups (Table 2). Mean ponderal index was higher among individuals 194 
with missing AMD data at AGES-II (n=580) than among those with AMD data at AGES-II (n=917), 26.3 195 
kg/m3, SD 3.4 vs. 25.6 kg/m3, SD 3.2; unadjusted p<0.01, but the difference became non-significant 196 
after adjusting for age (age-adjusted p=0.47, data not shown). 197 
 198 
There was no consistent or obvious relationship between AMD, PI and obesity. The prevalence 199 
(39.8%) and 5-year incidence (28.6%) of AMD were highest among individuals who belonged to the 200 
highest PI group at birth and who were obese in old age (Figure 1). In contrast, the prevalence of 201 
AMD was lowest (28.0%) among individuals in the lowest PI group at birth and medium group of 202 
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body weight in old age. The lowest 5-year incidence of AMD (12.8%) was observed for those in the 203 
medium PI group at birth and normal body weight in old age. 204 
 205 
No associations between body size at birth and prevalent AMD (examined at AGES-I and/or AGES-206 
II) were observed in analyses with data from women and men combined (data not shown) or when 207 
stratified by birth cohort (Table 3). When the AGES analytic sample was restricted to the birth years 208 
matching each of the other three published studies (Figure 2), the results were unchanged (data not 209 
shown). When the analysis was restricted to the first cross-sectional AMD measurement (examined 210 
at AGES-I), higher birth weight and ponderal index protected from prevalent AMD in 201 men born 211 
1925-29: 1-unit increases in birth weight (kg) and ponderal index (kg/m3) were associated with a 212 
decreased odds of AMD, odds ratio (OR) 0.64 (95% CI 0.43, 0.96) and OR 0.58 (95% CI 0.38, 0.90), 213 
for birth weight and ponderal index, respectively, adjusting for age, education, BMI, smoking, 214 
alcohol consumption, prevalent coronary heart disease and diabetes (data not shown). No 215 
associations were observed among women or in men belonging to the other two birth cohort strata 216 
(data not shown). 217 
 218 
When the three birth cohorts were pooled at AGES-I examination, a 1-unit increase in ponderal 219 
index was associated with a reduced OR of AMD among men (OR 0.79, 95% CI 0.64 to 0.97) but with 220 
increased OR of AMD among women (OR 1.19, 95% CI 1.00 to 1.41), adjusting for birth cohort (data 221 
not shown). The association was little changed after further adjustment for covariates in men (OR 222 
0.78, 95% CI 0.63 to 0.97) but became non-significant in women (OR 1.14, 95% CI 0.96, 1.36; data 223 




Data on body size at birth and incident AMD is presented in Table 4 stratified by birth cohort. A 1-226 
unit increase in birth weight (kg) was associated with an increased risk of incident AMD in those 227 
born 1925-29 whereas a 1-unit increase in ponderal index (kg/m3) was associated with a decreased 228 




Evidence from epidemiological studies stress the importance of developmental influences, 231 
particularly poor growth in utero, in susceptibility to chronic diseases (Wang et al. 2014, Zhang et 232 
al. 2013), of which several have been suggested to be concomitant risk factors for AMD (Cheung & 233 
Wong 2014). We found that body size at birth, which is a crude marker of intrauterine growth, was 234 
not consistently associated with AMD in old age. 235 
 236 
Evidence of an association between body size at birth and AMD suggest that a high birth weight may 237 
confer a modest risk of AMD in a White population, as was shown in some (Hall et al. 2002, Liew et 238 
al. 2008) but not all (Sayer et al. 1998) previous reports. The present study extends previous 239 
observations to  those aged 80 years and older, and to our knowledge, is the first to study the 240 
relationship between body size at birth and incident AMD. Icelanders have one of the highest mean 241 
birth weights in the World (Atladottir & Thorsdottir 2000). High rates of longevity in this population 242 
combined with its high rate of AMD, considerably higher than in other cohorts of comparable age 243 
(Jonasson et al. 2011), make this cohort uniquely suited to investigate an association between AMD 244 
and birth size. Although higher BMI in old age was previously found to be associated with incident 245 
AMD in AGES data (Jonasson et al. 2014), we found no evidence to support any trend between body 246 
size at birth and prevalent or 5-year incident AMD in this population of 1497 Icelanders aged 65 247 
years and older. Some associations between birth data and AMD were observed in the present 248 
study, however, they were inconsistent and disappeared after stratification by birth cohort and sex. 249 
 250 
The mechanisms underlying the plausible association between accelerated intrauterine growth, 251 
reflected in high birth weight, and AMD, are not known. In the present study, we found that both 252 
the prevalence and 5-year incidence of AMD were highest in individuals who belonged to the highest 253 
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group of ponderal index at birth and who were obese in old age. Rather than resulting directly from 254 
accelerated intrauterine growth, it is possible that a risk of AMD could be linked with metabolic 255 
programming of one of its risk factors, namely obesity, which has consistently been associated with 256 
higher birth weight (Yu et al. 2011). The authors of one study (Hall et al. 2002) proposed that 257 
individuals with AMD had disproportionately smaller head circumference to birth weight, possibly 258 
indicating that a pattern of retarded growth of structures in the brain, would be linked with AMD. 259 
However, we were not able to study that relationship in the present study due to lack of data on 260 
head circumference. 261 
 262 
Overall, while greater weight at birth has been associated with obesity (Yu et al. 2011), associations 263 
between small body size at birth, namely low birth weight, and aging-related chronic diseases 264 
(Harder et al. 2007, Wang et al. 2014, Zhang et al. 2013), geriatric syndromes including frailty 265 
(Haapanen et al. 2018) and measures of the aging process such as bone mass and muscle strength 266 
(Hanson et al. 2016), support a greater role of non-optimal intrauterine growth in the pathogenesis 267 
of aging-related chronic disease. This notion is supported by recent findings (Fieß et al. 2019) on eye 268 
development where a low birth weight was associated with a steeper corneal curvature, smaller 269 
corneal diameter, and thinner central cornea, in individuals aged 40-80 years, suggesting a potential 270 
role of intrauterine growth in anatomical alterations of the eye. 271 
 272 
A major strength of the present study is that it involved a relatively large sample of older persons 273 
with approximately 500 prevalent or incident cases of AMD, representing one third of the entire 274 
study population. Information on body size at birth was extracted from actual birth records and 275 
standardized fundus images were graded at the University of Wisconsin reading center for AMD. 276 
Information on gestational age and head circumference was not available, which limited our ability 277 
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in differentiating between prematurity and growth retardation in infants born at term in this cohort. 278 
Mortality and loss to follow-up may have resulted in selective survival of healthier participants as 279 
well as participants with possibly higher mean birth weights. However, mean body size at birth of 280 
the AGES participants without AMD data was similar to that of participants with AMD data who 281 
were included in the present study. While stratifying by birth cohort enabled us to minimize 282 
confounding due to chronological age, it also allowed us to consider, in a general sense, geo-283 
economic conditions indicative of Icelandic life at the time. Accordingly, body size at birth varied 284 
between the three birth cohorts. Those in the youngest cohort, born during the Great Depression 285 
in Reykjavik, Iceland, as illustrated in Figure 2, were consequently smaller in size at birth whereas 286 
those born between 1925 and 1929 were heavier at birth but gained less weight growing up during 287 
the Depression (Imai et al. 2012). Consistent with birth cohort effects reported for prevalent (Huang 288 
et al. 2003) and incident AMD from a US cohort (Klein et al. 2008), our results corroborate birth 289 
cohort effects in an Icelandic cohort, although generalizability to other populations, or other 290 
ethnicities, may be limited since both cohorts included only Caucasians.  Additionally, findings from 291 
this older Icelandic cohort may differ from subsequent generations of Icelanders of comparable age 292 
who were born after global travel became routine and the nation’s standard of living improved 293 
dramatically. 294 
 295 
In conclusion, body size at birth was not consistently associated with AMD in this White population 296 
characterized by high birth weight, longevity and higher than average rates of AMD. Therefore, 297 
prenatal exposures are likely to have little direct or independent effects on the development of AMD 298 
in old age. Indirect effects on AMD, however, may be mediated through other unmeasured factors 299 
that influence body size at birth and/or obesity in old age. It is possible that prevention of obesity 300 
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Table 1. Characteristics of Men and Women by Birth Cohort in the AGES-Reykjavik Study 380 


























Birth Data                
Birth Weight, grams 3792 (568) 3790 (561) 3669 (509) 0.02  3888 (553) 3915 (607) 3729 (527) 0.06  3709 (569) 3700 (508) 3621 (489) 0.12 
Birth Length, cm 52.2 (2.4) 52.2 (2.5) 52.8 (2.4) 0.03  52.7 (2.5) 52.7 (2.4) 53.2 (2.3) 0.30  51.8 (2.3) 51.9 (2.4) 52.5 (2.4) 0.07 
Ponderal Index 26.7 (3.7) 26.6 (3.4) 24.9 (2.7) < 0.01  26.7 (3.7) 26.8 (3.5) 24.8 (2.7) < 0.01  26.6 (3.7) 26.5 (3.3) 25.0 (2.7) < 0.01 
Birth Order    < 0.01     < 0.01     0.27 
First 21.6 (79) 25.1 (121) 37.3 (241)   20.6 (35) 20.4 (41) 37.8 (108)   12.0 (44) 28.5 (80) 36.9 (133)  
Second 25.4 (93) 22.0 (106) 25.4 (164)   26.5 (45) 22.9 (46) 25.5 (73)   24.5 (48) 21.4 (60) 25.3 (91)  
Third  16.9 (62) 17.8 (86) 15.0 (97)   19.4 (33) 17.9 (36) 15.0 (43)   14.8 (29) 17.8 (50) 15.0 (54)  
Fourth (+) 36.1 (132) 35.1 (169) 22.3 (144)   33.5 (57) 38.8 (78) 21.7 (62)   38.3 (75) 32.4 (91) 22.8 (82)  
Midlife Data               
Body Mass Index 25.9 (3.8) 25.0 (3.3) 25.2 (3.6) 0.04  26.2 (3.4) 25.3 (3.1) 25.8 (3.5) 0.33  25.6 (4.1) 24.8 (3.5) 24.7 (3.7) 0.15 
Systolic Blood Pressure 137.6 (17.8) 132.8 (17.3) 128.9 (15.3) 0.37  138.9 (19.0) 137.8 (16.7) 134.4 (14.7) 0.58  136.5 (16.7) 129.2 (16.8) 124.6 (14.3) 0.73 
Diastolic Blood Pressure 86.4 (10.2) 83.9 (10.0) 82.0 (9.5) 0.21  88.9 (11.2) 87.9 (10.3) 86.4 (9.3) 0.65  84.2 (8.7) 81.1 (8.8) 78.5 (8.1) 0.08 
Old Age Data               
Age 82.0 (2.3) 75.9 (1.7) 70.8 (2.1) < 0.01  82.1 (2.5) 76.1 (1.6) 71.2 (1.9) < 0.01  81.9 (2.1) 75.8 (1.8) 70.4 (2.3) < 0.01 
Body Mass Index 27.0 (4.4) 27.1 (4.3) 27.9 (4.7) 0.40  26.8 (3.6) 26.8 (3.7) 28.0 (4.1) 0.05  27.2 (5.0) 27.4 (4.7) 27.9 (5.1) 0.48 
Education, Completed Secondary 
or More 
78.5 (285) 78.2 (376) 85.3 (551) 0.14  83.8 (140) 90.0 (180) 89.9 (256) 0.32  74.0 (145) 69.8 (196) 81.7 (295) 0.37 
Never Smoked 43.7 (160) 42.7 (206) 33.9 (219) 0.74  33.7 (57) 29.9 (60) 24.2 (69) 0.27  52.3 (103) 52.0 (146) 41.6 (150) 0.12 
Alcohol Consumption,  
One or More Grams Per Week 
65.9 (241) 69.3 (332) 75.0 (484) < 0.01  69.8 (118) 73.5 (147) 80.7 (230) 0.22  62.4 (123) 66.3 (185) 70.6 (254 0.02 
Coronary Heart Disease 25.3 (93) 20.3 (98) 18.1 (117) 0.01  34.7 (59) 29.4 (59) 26.6 (76) 0.12  17.3 (34) 13.9 (39) 11.3 (41) 0.04 
Diabetes 14.7 (54) 11.6 (56) 7.7 (50) < 0.01  18.2 (31) 12.9 (26) 9.8 (28) 0.04  11.7 (23) 10.7 (30) 6.1 (22) < 0.01 
Total Cholesterol, mmol/l 5.6 (1.2) 5.7 (1.2) 5.7 (1.0) 0.01  5.1 (1.1) 5.2 (1.1) 5.3 (1.0) 0.15  6.0 (1.2) 6.0 (1.1) 5.9 (1.0) < 0.01 
High-Density Lipoprotein 
Cholesterol, mmol/l 
1.6 (0.5) 1.6 (0.5) 1.6 (0.5) 0.61  1.5 (0.4) 1.5 (0.5) 1.4 (0.4) 0.14  1.8 (0.5) 1.7 (0.4) 1.7 (0.5) 0.33 
CFH Genotype rs1061170**    0.07     0.04     0.30 
Allele TT 27.0 (44) 39.4 (84) 39.3 (88)   33.8 (25) 38.5 (30) 41.4 (41)   21.4 (19) 40.0 (54) 37.6 (47)  
           TC 54.0 (88) 46.0 (98) 45.5 (102)   52.7 (39) 50.0 (39) 45.5 (45)   55.1 (49) 43.7 (59) 45.6 (57)  
           CC 19.0 (31) 14.6 (31) 15.2 (34)   13.5 (10) 11.5 (9) 13.1 (13)   23.6 (21) 16.3 (22) 16.8 (21)  
AMD Status               
AMD at AGES-I    0.32     0.27     0.85 
None 57.8 (212) 75.1 (362) 84.9 (550)   61.2 (104) 79.6 (160) 85.7 (245)   54.8 (108) 71.9 (202) 84.3 (305)  
Any AMD 42.2 (155) 24.9 (120) 15.1 (98)   38.8 (66) 20.4 (41) 14.3 (41)   45.2 (89) 28.1 (79) 15.8 (57)  
Early AMD 32.2 (118) 22.0 (106) 12.7 (82)   30.0 (51) 18.4 (37) 12.9 (37)   34.0 (67) 24.6 (69) 12.4 (45)  
Late AMD 10.1 (37) 2.9 (14) 2.5 (16)   8.8 (15) 2.0 (4) 1.4 (4)   11.2 (22) 3.6 (10) 3.3 (12)  
Prevalent AMD at AGES-I or II    0.21     0.09     0.83 
None 49.6 (182) 67.4 (325) 76.2 (494)   54.7 (93) 69.2 (139) 80.1 (229)   45.2 (89) 66.2 (186) 73.2 (265)  
Any AMD 50.4 (185) 32.6 (157) 23.8 (154)   45.3 (77) 30.9 (62) 19.9 (57)   54.8 (108) 33.8 (95) 26.8 (97)  
Early AMD 36.2 (133) 26.8 (129) 19.9 (129)   34.1 (58) 26.4 (53) 17.1 (49)   38.1 (75) 27.1 (76) 22.1 (80)  
Late AMD 14.2 (52) 5.8 (28) 3.9 (25)   11.2 (19) 4.5 (9) 2.8 (8)   16.8 (33) 6.8 (19) 4.7 (17)  
Incident AMD at AGES-II***    0.10     0.12     0.54 
None 62.0 (49) 84.3 (199) 86.3 (353)   64.5 (20) 79.0 (79) 91.1 (163)   60.4 (29) 88.2 (120) 82.6 (190)  
Any AMD 38.0 (30) 15.7 (37) 13.7 (56)   35.5 (11) 21.0 (21) 8.9 (16)   39.6 (19) 11.8 (16) 17.4 (40)  
Results are presented as mean (standard deviation) or percentage (count). 381 
* Comparison of each characteristic, adjusting for age at AGES-I and sex, by birth cohort. 382 
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** CFH genotype rs1061170 data available for only N=600 individuals in this sample. 383 




Table 2. Mean Ponderal Index by Birth Cohort and Prevalent and Incident Age-Related Macular Degeneration in the AGES-386 
Reykjavik Study 387 
    Mean Ponderal Index   Mean Ponderal Index 
Birth Cohort 
Prevalent AMD  















1914-1924 No 26.6 (3.9) 27.0 (4.1) 26.3 (3.7) No 27.5 (4.9) 28.4 (4.6) 26.9 (5.0) 
  Yes 26.7 (3.5) 26.3 (3.1) 26.9 (3.7) Yes 25.6 (3.4) 26.0 (3.2) 25.4 (3.6) 
1925-1929 No 26.7 (3.3) 26.9 (3.5) 26.5 (3.1) No 26.4 (3.3) 26.6 (3.6) 26.3 (3.1) 
  Yes 26.5 (3.5) 26.5 (3.4) 26.5 (3.6) Yes 26.9 (3.2) 27.8 (3.4) 25.9 (2.8) 
1930-1936 No 24.9 (2.7) 24.8 (2.7) 25 (2.6) No 24.9 (2.6) 24.6 (2.6) 25.1 (2.6) 
  Yes 24.9 (2.8) 24.8 (2.6) 25 (2.9) Yes 24.6 (2.7) 24.3 (2.8) 24.7 (2.7) 
Total No 25.8 (3.3) 25.9 (3.5) 25.7 (3.1) No 25.6 (3.2) 25.5 (3.4) 25.7 (3.1) 
  Yes 26.1 (3.4) 25.9 (3.2) 26.2 (3.5) Yes 25.6 (3.2) 26.2 (3.4) 25.2 (3.0) 
  Early 25.9 (3.3) 25.7 (3.1) 26.1 (3.4)     
  Late 26.6 (3.8) 26.8 (3.5) 26.5 (3.9)     
Ponderal Index = kg/m3 388 
Results are presented as means (standard deviation). 389 
* Incident AMD at AGES-II defined as having no AMD at AGES-I baseline but having AMD at AGES-II examination. Incident AMD is only categorized 390 
as none or any AMD due to the extremely small number of cases of incident late AMD (e.g. N=4 with 1 case in 1914-1924 cohort, 2 cases in 1925-391 
1929 cohort, and 1 case in 1930-1936 cohort).   392 
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Table 3. Logistic Regression Models for Age-Related Macular Degeneration in Old Age by Body Size at Birth in Men and Women 393 
from the AGES-Reykjavik Study, Stratified by Birth Cohort, Odds Ratios and 95% Confidence Intervals 394 
 
Prevalent AMD at 
AGES-I or AGES-II Any AMD Early AMD 
Birth Cohort 1914-1924 1925-1929 1930-1936 1914-1924 1925-1929 1930-1936 
All Individuals        
Birth Weight (kg) 1.03 (0.83, 1.28) 0.97 (0.79, 1.20) 0.94 (0.77, 1.13) 1.02 (0.80, 1.30) 0.96 (0.77, 1.20) 0.85 (0.69, 1.04) 
Birth Length (cm) 1.08 (0.87, 1.34) 1.08 (0.87, 1.33) 0.93 (0.77, 1.12) 1.09 (0.86, 1.39) 1.08 (0.87, 1.35) 0.86 (0.70, 1.06) 
Ponderal Index 0.95 (0.77, 1.18) 0.92 (0.75, 1.13) 0.99 (0.82, 1.20) 0.91 (0.72, 1.16) 0.90 (0.72, 1.12) 0.98 (0.80, 1.19) 
Men        
Birth Weight (kg) 0.89 (0.65, 1.24) 0.93 (0.67, 1.30) 0.99 (0.72, 1.34) 0.90 (0.63, 1.30) 0.92 (0.65, 1.30) 0.83 (0.59, 1.15) 
Birth Length (cm) 1.10 (0.78, 1.54) 1.02 (0.73, 1.42) 0.94 (0.69, 1.29) 1.12 (0.77, 1.63) 1.01 (0.71, 1.43) 0.86 (0.62, 1.21) 
Ponderal Index 0.78 (0.55, 1.10) 0.89 (0.64, 1.23) 1.02 (0.75, 1.40) 0.75 (0.51, 1.11) 0.87 (0.62, 1.23) 0.89 (0.64, 1.25) 
Women        
Birth Weight (kg) 1.14 (0.84, 1.53) 1.03 (0.79, 1.35) 0.93 (0.73, 1.18) 1.11 (0.80, 1.55) 1.03 (0.77, 1.37) 0.88 (0.67, 1.14) 
Birth Length (cm) 1.00 (0.74, 1.35) 1.13 (0.86, 1.48) 0.93 (0.73, 1.19) 0.97 (0.71, 1.35) 1.14 (0.86, 1.53) 0.87 (0.67, 1.14) 
Ponderal Index 1.16 (0.86, 1.57) 0.95 (0.73, 1.24) 0.98 (0.77, 1.25) 1.14 (0.82, 1.59) 0.94 (0.70, 1.25) 1.02 (0.79, 1.32) 
Ponderal Index = kg/m3 395 
Results are presented as odds ratios and 95% confidence intervals. 396 
Models are adjusted for sex (in combined analyses of all individuals), and education, age at AGES-I, BMI, smoking, alcohol consumption, prevalent 397 
coronary heart disease, diabetes, total cholesterol, and HDL cholesterol.  398 
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Table 4. Logistic Regression Models for Incident Age-Related Macular Degeneration in Old Age by Body Size at Birth in Men and 399 
Women from the AGES-Reykjavik Study, Stratified by Birth Cohort, Odds Ratios and 95% Confidence Intervals 400 
 
Incident AMD at AGES-II Any AMD 
Birth Cohort 1914-1924 1925-1929 1930-1936 
All Individuals    
Birth Weight (kg) 0.65 (0.39, 1.10) 1.51 (1.01, 2.27) 0.81 (0.60, 1.10) 
Birth Length (cm) 1.14 (0.68, 1.92) 1.39 (0.94, 2.05) 0.91 (0.67, 1.22) 
Ponderal Index 0.50 (0.28, 0.92) 1.13 (0.77, 1.64) 0.87 (0.64, 1.18) 
Men    
Birth Weight (kg) 0.44 (0.12, 1.58) 1.64 (0.86, 3.13) 0.88 (0.49, 1.57) 
Birth Length (cm) 0.86 (0.17, 4.36) 1.07 (0.60, 1.91) 0.95 (0.54, 1.66) 
Ponderal Index 0.20 (0.02, 1.77) 1.61 (0.86, 3.01) 0.89 (0.47, 1.67) 
Women    
Birth Weight (kg) 0.76 (0.38, 1.53) 1.46 (0.83, 2.60) 0.79 (0.54, 1.16) 
Birth Length (cm) 1.11 (0.54, 2.25) 1.70 (0.96, 3.01) 0.90 (0.63, 1.30) 
Ponderal Index 0.62 (0.28, 1.35) 0.83 (0.45, 1.55) 0.86 (0.60, 1.24) 
Ponderal Index = kg/m3 401 
Results are presented as odds ratios and 95% confidence intervals. 402 
Models are adjusted for sex (in combined analyses of all individuals), and education, age at AGES-I, BMI, smoking, alcohol consumption, prevalent 403 
coronary heart disease, diabetes, total cholesterol and HDL cholesterol.  404 
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Figure 1B. Percentage of Individuals with Incident AMD by Ponderal Index and BMI at AGES-I 411 
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Figure 2  
Supplemental Table 1. Mortality and Age-Related Macular Degeneration for Individuals in the AGES-Reykjavik Study who have Birth Size data 






















AGES-I AMD Status Available           
Yes 88.5 (1497) 80.8 (367) 91.1 (482) 91.5 (648) 81.3 (170) 91.0 (201) 91.1 (286) 80.4 (197) 91.2 (281) 91.9 (362) 
No 11.5 (194) 19.2 (87) 8.9 (47) 8.5 (60) 18.7 (39) 9.1 (20) 8.9 (28) 19.6 (48) 8.8 (27) 8.1 (32) 
Died before Examination* 77.8 (151) 95.4 (83) 76.6 (36) 53.3 (32) 100.0 (39) 70.0 (14) 64.3 (18) 91.7 (44) 81.5 (22) 43.8 (14) 
Missing for Other Reason* 22.2 (43) 4.6 (4) 23.4 (11) 46.7 (28) 0.0 (0) 30.0 (6) 35.7 (10) 8.3 (4) 18.5 (5) 56.2 (18) 






















AGES-II AMD Status Available           
Yes 61.3 (917) 37.1 (136) 62.2 (300) 74.2 (481) 29.4 (50) 61.7 (124) 73.8 (211) 43.6 (86) 62.6 (176) 74.6 (270) 
No 38.7 (580) 62.9 (231) 37.8 (182) 25.8 (167) 70.6 (120) 38.3 (77) 26.2 (75) 56.4 (111) 37.4 (105) 25.4 (92) 
Died before Examination* 36.7 (213) 36.8 (85) 35.2 (64) 38.3 (64) 38.3 (46) 44.2 (34) 49.3 (37) 35.1 (39) 28.6 (30) 29.3 (27) 
Missing for Other Reason* 63.3 (367) 63.2 (146) 64.8 (118) 61.7 (103) 61.7 (74) 55.8 (43) 50.7 (38) 64.9 (72) 71.4 (75) 70.7 (65) 
* Percentage denominator is the number of individuals who do not have available AMD status (e.g. 'No').      
a Sample of individuals with birth size data who participated in the AGES-Reykjavik study.     
b Sample of individuals with birth size data and AGES-I AMD data who participated in the AGES-Reykjavik study.  
 
